Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer
Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor...
Hida, Toyoaki
2007-01-01 00:00:00
Detection of common EGFR mutations seems to be useful for selecting patients with NSCLC who would likely benefit from gefitinib monotherapy.
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngJournal of Thoracic OncologyWolters Kluwer Healthhttp://www.deepdyve.com/lp/wolters-kluwer-health/prospective-validation-for-prediction-of-gefitinib-sensitivity-by-lqB8xsVv1t
Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.